Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates

11 Oct 2022

Abstract excerpt

Abstract Background Proteus mirabilisis an opportunistic pathogen, causing a variety of community-acquired and nosocomial illnesses. It poses a potential threat to patients via the production of β-lactamases, which decrease the efficacy of antimicrobial treatment and impair the management of its pathogenicity. Hence, this study was established to determine the prevalence of extended-spectrum β-lactamases (ESBLs),...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Infections and bacterial resistance
Share to Nosocomial Infections in ICU

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36221063
DOI: 10.1186/s12866-022-02662-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolatesPMID 36221063Read ↗

Phenotypic and genotypic characterization of Extended Spectrum β-lactamases producing Proteus mirabilis isolates.Semantic proximity Read ↗

Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.Semantic proximity Read ↗

Evolution of β-Lactam Antibiotic Resistance in Proteus Species: From Extended-Spectrum and Plasmid-Mediated AmpC β-Lactamases to CarbapenemasesSemantic proximity Read ↗

Detection of β-Lactamase-Producing Proteus mirabilis Strains of Animal Origin in Andhra Pradesh, India and Their Genetic Diversity.Semantic proximity Read ↗

Evolution of β-Lactam Antibiotic Resistance in <i>Proteus</i> Species: From Extended-Spectrum and Plasmid-Mediated AmpC β-Lactamases to CarbapenemasesSemantic proximity Read ↗

Genetic analysis of resistance and virulence characteristics of clinical multidrug-resistant Proteus mirabilis isolatesSemantic proximity Read ↗

Antimicrobial susceptibility and distribution of extended-spectrum β-lactamases, AmpC β-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008–2011Semantic proximity Read ↗

Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.Semantic proximity Read ↗

Increase in -lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type -lactamasesSemantic proximity Read ↗

Genetic characteristics of chromosomally integrated carbapenemase gene (blaNDM−1) in isolates of Proteus mirabilisSemantic proximity Read ↗

Genomic Constellation of Foodborne Proteus Mirabilis Isolates Harboring AMR, Virulence Genes and Comparative WGS Analysis.Semantic proximity Read ↗

Multidrug‐resistant Proteus mirabilis isolates carrying blaOXA‐1 and blaNDM‐1 from wildlife in China: increasing public health riskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.